PICADOR acquired world rights to a debut novel by Paul Goldberg, editor and publisher of The Cancer Letter. Set in Moscow in late February and early March of 1953, the novel is only in part about medicine. It’s expected to be published in early 2016.
A group of melanoma experts, joined by three advocacy groups focused on melanoma, has engaged FDA in a public discussion of the challenges of developing new drugs in the refractory setting and the role crossover can play in such trials.
